Rockwell Medical (RMTI) to Release Earnings on Thursday

Rockwell Medical (NASDAQ:RMTIGet Free Report) is set to release its earnings data before the market opens on Thursday, March 21st. Analysts expect Rockwell Medical to post earnings of ($0.08) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Rockwell Medical Trading Up 1.4 %

Shares of RMTI stock opened at $1.41 on Wednesday. The stock has a market cap of $40.17 million, a price-to-earnings ratio of -2.56 and a beta of 1.16. The company has a quick ratio of 1.06, a current ratio of 1.32 and a debt-to-equity ratio of 0.23. Rockwell Medical has a fifty-two week low of $1.16 and a fifty-two week high of $6.24. The firm’s 50 day moving average price is $1.40 and its two-hundred day moving average price is $1.73.

Institutional Trading of Rockwell Medical

A number of hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Rockwell Medical by 185.3% in the fourth quarter. Vanguard Group Inc. now owns 1,074,975 shares of the company’s stock worth $2,032,000 after buying an additional 698,160 shares during the last quarter. HighTower Advisors LLC bought a new stake in shares of Rockwell Medical in the third quarter worth $68,000. Osaic Holdings Inc. increased its stake in Rockwell Medical by 205.4% during the second quarter. Osaic Holdings Inc. now owns 7,583 shares of the company’s stock valued at $42,000 after purchasing an additional 5,100 shares during the last quarter. XTX Topco Ltd bought a new stake in Rockwell Medical during the second quarter valued at $127,000. Finally, Tower Research Capital LLC TRC increased its stake in Rockwell Medical by 112.6% during the second quarter. Tower Research Capital LLC TRC now owns 10,284 shares of the company’s stock valued at $56,000 after purchasing an additional 5,447 shares during the last quarter. Hedge funds and other institutional investors own 22.07% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Rockwell Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, November 22nd.

Read Our Latest Stock Analysis on RMTI

Rockwell Medical Company Profile

(Get Free Report)

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in patients undergoing hemodialysis.

See Also

Earnings History for Rockwell Medical (NASDAQ:RMTI)

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.